AT325206B - Verfahren zur herstellung von neuen alpha-sulfobenzylpenicillinsalzen - Google Patents

Verfahren zur herstellung von neuen alpha-sulfobenzylpenicillinsalzen

Info

Publication number
AT325206B
AT325206B AT576473A AT576473A AT325206B AT 325206 B AT325206 B AT 325206B AT 576473 A AT576473 A AT 576473A AT 576473 A AT576473 A AT 576473A AT 325206 B AT325206 B AT 325206B
Authority
AT
Austria
Prior art keywords
sulfobenzylpenicillin
salts
production
new alpha
alpha
Prior art date
Application number
AT576473A
Other languages
German (de)
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of AT325206B publication Critical patent/AT325206B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT576473A 1972-07-01 1973-06-29 Verfahren zur herstellung von neuen alpha-sulfobenzylpenicillinsalzen AT325206B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (US07981874-20110719-C00313.png) 1972-07-01 1972-07-01

Publications (1)

Publication Number Publication Date
AT325206B true AT325206B (de) 1975-10-10

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT576473A AT325206B (de) 1972-07-01 1973-06-29 Verfahren zur herstellung von neuen alpha-sulfobenzylpenicillinsalzen

Country Status (15)

Country Link
US (1) US3925357A (US07981874-20110719-C00313.png)
JP (1) JPS5512435B2 (US07981874-20110719-C00313.png)
AT (1) AT325206B (US07981874-20110719-C00313.png)
AU (1) AU469986B2 (US07981874-20110719-C00313.png)
BE (1) BE801588A (US07981874-20110719-C00313.png)
CA (1) CA996548A (US07981874-20110719-C00313.png)
CH (1) CH573435A5 (US07981874-20110719-C00313.png)
CS (1) CS168036B2 (US07981874-20110719-C00313.png)
DE (1) DE2332840A1 (US07981874-20110719-C00313.png)
FR (1) FR2190414B1 (US07981874-20110719-C00313.png)
GB (1) GB1386566A (US07981874-20110719-C00313.png)
HU (1) HU166029B (US07981874-20110719-C00313.png)
NL (1) NL7308048A (US07981874-20110719-C00313.png)
PL (1) PL92969B1 (US07981874-20110719-C00313.png)
SE (1) SE402916B (US07981874-20110719-C00313.png)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (US07981874-20110719-C00313.png) * 1978-07-29 1980-02-13
CZ305402B6 (cs) * 2001-02-24 2015-09-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthinové deriváty, jejich výroba a použití v kombinační terapii
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
CA2810522A1 (en) * 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh Polymorphs
PE20110235A1 (es) * 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
CN101784278A (zh) * 2007-08-17 2010-07-21 贝林格尔.英格海姆国际有限公司 用于治疗fab-相关的疾病的嘌呤衍生物
PE20091730A1 (es) * 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
KR101791403B1 (ko) * 2008-08-15 2017-10-30 베링거 인겔하임 인터내셔날 게엠베하 Fab-관련 질환의 치료에 사용하기 위한 퓨린 유도체
US8513264B2 (en) 2008-09-10 2013-08-20 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en) 2008-12-23 2015-09-03 Boehringer Ingelheim International Gmbh Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR102668834B1 (ko) 2009-11-27 2024-05-24 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
CN102946875A (zh) 2010-05-05 2013-02-27 贝林格尔.英格海姆国际有限公司 组合疗法
NZ603319A (en) 2010-06-24 2015-04-24 Boehringer Ingelheim Int Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US8962636B2 (en) 2011-07-15 2015-02-24 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP3685839A1 (en) 2012-05-14 2020-07-29 Boehringer Ingelheim International GmbH Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
MX2018015089A (es) 2016-06-10 2019-05-13 Boehringer Ingelheim Int Combinacion de linagliptina y metformina.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (US07981874-20110719-C00313.png) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
PL92969B1 (US07981874-20110719-C00313.png) 1977-04-30
BE801588A (fr) 1973-12-28
SE402916B (sv) 1978-07-24
CA996548A (en) 1976-09-07
CS168036B2 (US07981874-20110719-C00313.png) 1976-05-28
JPS5512435B2 (US07981874-20110719-C00313.png) 1980-04-02
NL7308048A (US07981874-20110719-C00313.png) 1974-01-03
AU5760073A (en) 1975-01-09
CH573435A5 (US07981874-20110719-C00313.png) 1976-03-15
GB1386566A (en) 1975-03-12
HU166029B (US07981874-20110719-C00313.png) 1974-12-28
FR2190414A1 (US07981874-20110719-C00313.png) 1974-02-01
US3925357A (en) 1975-12-09
FR2190414B1 (US07981874-20110719-C00313.png) 1976-07-02
DE2332840A1 (de) 1974-01-17
AU469986B2 (en) 1976-02-26
JPS4925121A (US07981874-20110719-C00313.png) 1974-03-06

Similar Documents

Publication Publication Date Title
AT325206B (de) Verfahren zur herstellung von neuen alpha-sulfobenzylpenicillinsalzen
AT325205B (de) Verfahren zur herstellung von neuen cephalosporin-salzen
ATA569473A (de) Verfahren zur herstellung von neuen enolderivaten
AT329068B (de) Verfahren zur herstellung von neuen chinoxalin-di -n- oxid-derivaten
AT335418B (de) Verfahren zur herstellung von neuen alkylthiocyclopentanderivaten
AT327194B (de) Verfahren zur herstellung von neuen 2-alkylamino-dihydropyridinen
AT327942B (de) Verfahren zur herstellung von neuen n-phenyl-carbaminsaure- beta -phenoxyathylestern
AT331425B (de) Verfahren zur herstellung von neuen d-2-halogen-6-methyl-8-subst.-methylergolinen
AT340072B (de) Verfahren zur herstellung von neuen pregnansaure-derivaten
AT332395B (de) Verfahren zur herstellung von neuen fluor-substituierten thioxanthenen
AT323148B (de) Verfahren zur herstellung von neuen 5-aroylfuranderivaten
ATA593373A (de) Verfahren zur herstellung von neuen dihydrodigoxin-derivaten
AT340066B (de) Verfahren zur herstellung von neuen morphinanderivaten
AT327406B (de) Verfahren zur herstellung von neuen scopolaminderivaten
AT319218B (de) Verfahren zur Herstellung von neuen Aminopropanderivaten
AT331250B (de) Verfahren zur herstellung von neuen piperazinderivaten
AT324328B (de) Verfahren zur herstellung von neuen tetrahydropyran- bzw. -thiopyranderivaten
AT338818B (de) Verfahren zur herstellung von neuen phenylguanidin-derivaten
AT330765B (de) Verfahren zur herstellung von neuen imidazoliumsalzen
AT332542B (de) Verfahren zur herstellung von neuen 7-acylamido -1-x-1- dethiacephalosporinderivaten
AT327169B (de) Verfahren zur herstellung von neuen n-(4-fluoranilinocarbonylmethyl)-n-alkyl-dimethylammoniumverbindungen
AT330369B (de) Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- amino-propanen
ATA137175A (de) Verfahren zur herstellung von neuen aminophenyl-athanolaminen
ATA844275A (de) Verfahren zur herstellung von neuen dl-7-azidocephalosporinverbindungen
ATA569773A (de) Verfahren zur herstellung von neuen 7beta-amino-cepham-3-on-4-carbonsaureverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee